X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Digital Science partners with Zhipu.AI to conduct data challenges and build COVID-19 information portal

Content Team by Content Team
7th April 2020
in Drug Development, News
Digital Science partners with Zhipu.AI to conduct data challenges and build COVID-19 information portal
Digital Science, a leading technology company serving emergent needs across the research sector, is pleased to announce a partnership with Beijing-based technology company Zhipu.AI to conduct data challenges and collaborate in building a COVID-19 information portal.
Zhipu.AI, a spin-out from Tsinghua University, aims to build an advanced artificial intelligence engine that can support and empower the research and innovation sectors globally. The company focuses on solving the current challenges of research organisations and government agencies, by using its extensive experience in analysing large-scale complex networks, deep semantic mining and leveraging innovative techniques with cognitive graphs.
This strategic collaboration will see the two companies work together on a broad range of projects over the next several years. Some of the existing opportunities planned for the collaboration include joint hosting of a new set of data challenges centred around scholarly communications problems such as name disambiguation; and bringing together advanced analysis tools from both companies to create deeper insights for the sector. Collaboration will be a central theme of the new relationship and will see Digital Science’s Overleaf made more seamlessly available to more Chinese users, enabling them to create, edit and publish their research all from one browser using the real-time collaborative LaTeX editor.
Professor Jie Tang, Chief Scientist at Zhipu, said: “Digital Science and Zhipu.AI are united by a common goal, that is, to leverage technology to improve information flows and encourage collaboration to facilitate research and innovation.
“With our combined strengths in advanced digital technologies and insights into the scientific ecosystem from both a global and regional perspective, we are able to build more intelligent and reliable tools to encourage the exchange of ideas and improve research practices to better serve the needs of the research community. We look forward to a fruitful partnership and are excited about our first joint initiatives on data challenges and the COVID-19 information portal.”
This partnership comes at a critical time with the global threat posed by COVID-19. Both teams will work together to ensure that both English and Chinese-language information is as widely shared as possible by providing a COVID-19 information portal with all related publications, datasets and clinical trials exported into a google sheet and hosted on Digital Science’s Figshare, as well as a dedicated website. The google sheet and website will be updated daily pulling all relevant content on COVID-19 from Digital Science’s Dimensions platform, to make sharing and distributing this research information easier.
Daniel Hook, CEO Digital Science, said: “It is a pleasure to be working with colleagues from Zhipu.AI. Just as in academia itself, international collaborations between companies that support the emerging global research infrastructure are critical to establishing the tools and cultures that allow us to act globally to tackle the world’s hardest problems. We are proud to launch this initiative with our partners in China and look forward to sharing the fruits of this collaboration with colleagues, partners and clients around the world.”
Digital Science is a technology company working to make research more efficient. We invest in, nurture and support innovative businesses and technologies that make all parts of the research process more open and effective. Our portfolio includes admired brands including Altmetric, CC Grant Tracker, Dimensions, Figshare, Gigantum, ReadCube, Symplectic, IFI Claims, GRID, Overleaf, Ripeta, Scismic and Writefull. We believe that together, we can help researchers make a difference.
Previous Post

New COVID-19 at-home test with social distancing ready for validation study

Next Post

Thermo Fisher Scientific Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (RUO)

Related Posts

Clinical Development
Articles

AI Revolutionizing Drug Discovery and Clinical Development

19th April 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Drug-Development
Articles

China’s Super Me-Too Drug Development: A New Pharma Frontier

18th April 2025
Omics Based Clinical Trials
Asia

Asia Pacific Omics-Based Clinical Trials Market Growth

16th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Insights

AstraZeneca Eyes Acquisition To Develop Cell Therapies

24th March 2025
Next Post
Thermo Fisher Scientific Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (RUO)

Thermo Fisher Scientific Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (RUO)

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In